Fosun International’s Oncorus, Inc. ONCR Stock Holding History

Fosun International’s Portfolio ONCR Stock Details ONCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-962,323	Closed	-$327K	–	63
2023 Q1	$327K	Hold	962,323	–	–	0.03%	58
2022 Q4	$244K	Hold	962,323	–	–	0.02%	65
2022 Q3	$818K	Hold	962,323	–	–	0.09%	56
2022 Q2	$1.21M	Hold	962,323	–	–	0.17%	52
2022 Q1	$1.71M	Hold	962,323	–	–	0.15%	94
2021 Q4	$5.07M	Buy	962,323 +2	+0%	+$15	0.29%	65
2021 Q3	$8.99M	Hold	962,321	–	–	0.46%	34
2021 Q2	$13.3M	Hold	962,321	–	–	0.79%	19
2021 Q1	$13.4M	Hold	962,321	–	–	1.05%	14
2020 Q4	$31.1M	Buy	+962,321	New	+$22.3M	2.03%	12

Other funds holding ONCR

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

YAL

Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

Fosun International's ONCR Position: Q2 2023 in Review

Fosun International sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 962,323 shares — an estimated $327K sold.

Fosun International first reported a position in ONCR in Q4 2020 and held it in 10 quarters. The position peaked at $31.1M in Q4 2020. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

Fosun International reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
Fosun International sold 962,323 Oncorus, Inc. shares in Q2 2023, an estimated $327K.
Fosun International first reported a position in Oncorus, Inc. in Q4 2020 and held it in 10 quarters.
Fosun International's Oncorus, Inc. position peaked at $31.1M in Q4 2020.
4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on Fosun International's 13F filing for Q2 2023, filed 14 Aug 2023.